Literature DB >> 15798408

Febrile complications following insertion of 100 double-J ureteral stents.

Alona Paz1, Gilad E Amiel, Neora Pick, Boaz Moskovitz, Ofer Nativ, Israel Potasman.   

Abstract

BACKGROUND AND
PURPOSE: Implanted foreign bodies are associated with a higher risk of infection. Little has been published on infectious complications associated with ureteral double-J stents. The aim of this study was to define risk factors and characterize the febrile complications of the insertion of double-J stents. PATIENTS AND METHODS: One hundred consecutive cases of retrograde stent insertion (55 men and 45 women) were evaluated retrospectively. Eighty-one patients had an obstructing stone, either in the ureter or at the ureteropelvic junction; 10 had an obstructing tumor; and 9 had hydronephrosis and pain without calculi. Risk assessment was calculated for two major categories: urgent (N = 47) and elective (N = 53) insertion. Potentially confounding factors such as age, sex, accompanying medical problems, and types of prophylaxis were assessed. All but six patients received prophylactic antibiotics prior to stent insertion.
RESULTS: All thirteen patients who had fever at the initial evaluation underwent urgent stent insertion. Of the 87 afebrile patients (53 elective and 34 urgent insertions), 22 (25%) developed fever (> or = 38 degrees C) after the procedure. Fever developed in 19 (56%) of the 34 urgent-insertion group who were not originally febrile as opposed to 3 (6%) of the elective-insertion group (P < 0.001). Six of these 22 patients (27%) had a positive urine culture after insertion. None had a positive blood culture, including the 13 patients who underwent the procedure while febrile.
CONCLUSIONS: Urgent insertion of a double-J stent is associated with a high risk of fever but a favorable outcome.

Entities:  

Mesh:

Year:  2005        PMID: 15798408     DOI: 10.1089/end.2005.19.147

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  7 in total

Review 1.  Current status of ureteral stent technologies: comfort and antimicrobial resistance.

Authors:  Carlos E Mendez-Probst; Alfonso Fernandez; John D Denstedt
Journal:  Curr Urol Rep       Date:  2010-03       Impact factor: 3.092

2.  Update on ureteral stent technology.

Authors:  Dirk Lange; Ben H Chew
Journal:  Ther Adv Urol       Date:  2009-08

Review 3.  Ureteral stent symptoms and associated infections: a biomaterials perspective.

Authors:  Ben H Chew; Dirk Lange
Journal:  Nat Rev Urol       Date:  2009-07-14       Impact factor: 14.432

4.  Ureteral Stent Microbiota Is Associated with Patient Comorbidities but Not Antibiotic Exposure.

Authors:  Kait F Al; John D Denstedt; Brendan A Daisley; Jennifer Bjazevic; Blayne K Welk; Stephen E Pautler; Gregory B Gloor; Gregor Reid; Hassan Razvi; Jeremy P Burton
Journal:  Cell Rep Med       Date:  2020-09-22

5.  Effects of specific alpha-1A/1D blocker on lower urinary tract symptoms due to double-J stent: a prospectively randomized study.

Authors:  Chung-Jing Wang; Shi-Wei Huang; Chien-Hsing Chang
Journal:  Urol Res       Date:  2009-03-10

6.  Risk factors for lower urinary tract infection and bacterial stent colonization in patients with a double J ureteral stent.

Authors:  Ali Ferruh Akay; Uğur Aflay; Abdullah Gedik; Hayrettin Sahin; Mehmet Kamuran Bircan
Journal:  Int Urol Nephrol       Date:  2006-12-14       Impact factor: 2.266

7.  Effects of Continuous Catheterization on Reducing Postoperative Urinary Tract Infection in Cervical Cancer Patients with Double J Stent Placement.

Authors:  Tengteng Liu; Yuan Yao; Xinwen Xing; Daming Chu
Journal:  J Healthc Eng       Date:  2021-11-09       Impact factor: 2.682

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.